AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2024
Mar 25, 2024
33298_dirs_2024-03-25_6a028876-4f40-432c-b463-f14a082b81de.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2024-03-21
Reporting Person: Yecies Eric Harold (General Counsel & CCO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-21 | Common Stock | A | 56250 | — | Acquired | 271250 | Direct |
Footnotes
F1: Performance shares vested on March 21, 2024.
F2: The total shares beneficially owned reflect a correction to previously reported ownership.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17